Amount Raised
$350 Million
Round Type
Funding Round
West ColumbiaBiotechnologyHealth CarePharmaceuticalInvestors
Description
Nephron Pharmaceuticals Corporation ("Nephron") today celebrated a successful $350 million capital raise – led by BlackRock Capital Investment Advisors, LLC ("BlackRock") and PNC Bank, National Association ("PNC) – to support future growth of the pharmaceutical manufacturer.
Who else raised in Pharmaceutical and Biotechnology around the same time
Companies in the same sectors as Nephron Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- INNOCAN PHARMA Corp raised an undisclosed amount (Funding Round) on October 20, 2023.
- Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.
- Amplifier Therapeutics raised an undisclosed amount (Funding Round) on October 17, 2023.
- Acasti raised $7.5M (Post-IPO Equity) on September 26, 2023.
- Acasti raised $7.5M on September 25, 2023.
Who to call at Nephron Pharmaceuticals, and when
A new round usually means Nephron Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nephron Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nephron Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nephron Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nephron Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nephron Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.